Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Brandeis University

Headquarters: Waltham, MA, United States of America
Year Founded: 1948
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Sep 19, 2023
Emerging Company Profile

Magnet: taking molecular glues beyond protein degradation with $50M

The company discovers small molecules that induce desired protein-protein interactions using an arsenal of screening technologies
BioCentury | Dec 11, 2021
Finance

More dry powder for Newpath’s company creation strategy

Boston firm to build portfolio of 8-12 biotechs with $350M second fund
BioCentury | Apr 15, 2020
Emerging Company Profile

Backed by Third Rock-led syndicate, MOMA seeks new ATP-powered targets by interrogating 'molecular machines'

MOMA plans to take a systematic approach to surveying a class of enzymes involved in cellular processes
BioCentury | Jun 24, 2019
Tools & Techniques

A new flavor of allosteric modulators: synthetic proteins

Why a Brandeis-NYU team turned to proteins, rather than small molecules, for allosteric modulators
BioCentury | Sep 1, 2016
Distillery Therapeutics

Therapeutics: Caspase-1 (CASP1); α-synuclein (SNCA)

BioCentury | May 22, 2014
Distillery Therapeutics

Indication: Neurology

BioCentury | Sep 23, 2013
Regulation

Opioid outline

FDA hopes opioid developers can collaborate on newly required postmarket trials
BioCentury | Jun 20, 2013
Distillery Therapeutics

Indication: Neurology

BioCentury | Apr 3, 2013
Politics & Policy

Obama announces BRAIN initiative

Items per page:
1 - 10 of 29